Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 6.87% vs -0.41% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 27.49% vs 45.27% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 15.91% vs 15.59% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -13.29% vs -18.18% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of DaShenLin Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 0.64% vs -6.20% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 6.87% vs -0.41% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -15.71% vs 172.75% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 27.49% vs 45.27% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -6.06% vs 37.72% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 15.91% vs 15.59% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 24.50% vs -12.47% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -13.29% vs -18.18% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






